BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 64 filers reported holding BAUDAX BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $70,000 | – | 10,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 1,152,539 | $4,783,000 | 6.56% |
| Corsair Capital Management | 870,123 | $3,611,000 | 1.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 157,220 | $652,000 | 0.26% |
| Leap Investments LP | 19,000 | $79,000 | 0.05% |
| Alyeska Investment Group, L.P. | 815,384 | $3,384,000 | 0.05% |
| Ikarian Capital, LLC | 100,000 | $415,000 | 0.03% |
| Brandywine Global Investment Management, LLC | 187,252 | $778,000 | 0.01% |
| OLD MISSION CAPITAL LLC | 19,600 | $81,000 | 0.01% |
| Verition Fund Management LLC | 27,000 | $112,000 | 0.00% |
| Paloma Partners Management Co | 48,744 | $202,000 | 0.00% |